Monday, September 25, 2017
Majority of women do not know early signs of breast cancer, finds global survey by Avon
LONDON, Sept. 25, 2017 /PRNewswire/ -- Only two in five people (42%) are confident about recognising the changes to their breasts that could be a sign of cancer, according to a new survey of 19,000 respondents by Avon Products, Inc., the world's leading social selling company[i]. The findings also show there is a .....
Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapy
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their likelihood of disease recurrence and survival outcomes. The analysis of more than 9,000 prostate tumors also found evidence tha.....
Radiation-immunotherapy combination can slow tumor growth for some patients with metastatic late-stage cancer
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body's immune system to attack the cancer. In the phase II trial, patients with end-stage c.....
Adding radiation to chemotherapy may dramatically improve survival for advanced-stage NSCLC patients
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical tri.....

Long-term survival rates more than double previous estimates for locally advanced lung cancer
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- Long-term results of a phase III clinical trial indicate that survival rates for patients receiving chemoradiation for unresectable, locally advanced non-small cell lung cancer (NSCLC) may be more than twice as high as previous estimates. At five years following treatment w.....
International trial confirms safety, effectiveness of high-dose brachytherapy plus pelvic radiation for cervical cancer
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy, or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fractions of 7 Gray (Gy) e.....
Biomarker blood test predicts survival following localized lung cancer treatment
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized non-small cell lung cancer (NSCLC) and afford physicians additional lead time to personalize treatment for recurrent disease. Patients in the study with de.....
Study at urban cancer center finds 75 percent of its depressed patients were previously undiagnosed
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- A new study of patients at an urban cancer center points to a potentially serious problem that may limit the impact of clinical cancer care?undiagnosed depression. Among the 40 percent of patients at the center who were diagnosed with depression, three in four had not previ.....
Distress associated with missed appointments and hospital admission during cancer treatment
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- Psychological distress has long been associated with negative health outcomes for cancer patients, though specific reasons remain unclear. A new study finds that roughly half of all patients who reported having severe distress, which the National Comprehensive Cancer Networ.....
Qfix® Launches New Radiotherapy Positioning Technology for the More Precise Treatment of Breast Cancer
AVONDALE, Pa., Sept. 23, 2017 /PRNewswire/ -- Today, Qfix announced the release of the first-in-its-class kVue Access 360 G2 and Access Prone G2 positioning devices that promise to improve prone breast cancer treatment by significantly reducing radiation dose to healthy tissue while improving patient c.....
Elekta and IBA Enter an MOU Regarding a Comprehensive Partnership Including Joint Software Development and Sales to Advance Proton Therapy Treatments
SAN DIEGO, September 23, 2017 /PRNewswire/ -- Elekta (EKTA-B.ST) and Ion Beam Applications (IBA) announced today that they have entered a Memorandum of Understanding (MOU) to agree to work closely together in software development as well as the sales and marketing of each other's products. The announcement was made at the oc.....
Novodiax 10-Minute ihcDirect CK5 and Mart-1 (Melan A) Assays Available for IVD Use
HAYWARD, CA - 23 Sep, 2017 - Novodiax Inc announces the availability of the companys first two ihcDirect staining kits for in vitro diagnosti...
Ride for Life: Novartis employees embark on a 600-km bike ride for breast cancer
  • Over $70,000 raised in fundraising efforts for long distance cycling event
DORVAL, QC, Sept. 23, 2017 /CNW/ - Novartis Canada employees set off today on their 13th annual Ride for Life, a 600-kilometer cycling event that has raised over


  • The High-Tech Future of Home Healthcare
  • A Medical Implants Manufacturer Used Salesforce Effectiveness Solution to Improve Salesforce Performance Provided by Quantzig
  • Point of Care Technology Market :Company information, geographical data and Market Analysis
  • Dental Market Trends, Size, Growth, Leading Players, Opportunities and 2021 Global Analysis Forecasts Discussed in New Research Report
  • Human Genetics Market Dynamics, Comprehensive Analysis, Business Growth, Prospects and Opportunities 2016-2024

  • Targovax granted US Patent for mutant-RAS neoantigen platform lead products
  • Hammertoe Market US $ 450 Million Acquire A Massive Growth By 2023
  • Hammertoe Market US $ 450 Million Acquire A Massive Growth By 2023
  • Crux Quality Solutions To Exhibit And Demo Workflow Automation Tool, FlowBoard At ASTRO 2017 Annual Meeting
  • Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy

    About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines